Treatment regimens may compromise gut-microbiome-derived signatures for liver cirrhosis
- PMID: 33657385
- DOI: 10.1016/j.cmet.2021.02.012
Treatment regimens may compromise gut-microbiome-derived signatures for liver cirrhosis
Abstract
Many of the gut-microbiome-derived signatures for liver cirrhosis, especially the important ones, were likely under the influence of proton pump inhibitors (PPIs). Wu et al. suggest that drug usage is a confounding factor in metagenomics analysis that should be controlled for.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Comment in
-
Proton pump inhibitor use status does not modify the microbiome signature for cirrhosis.Cell Metab. 2021 Mar 2;33(3):457. doi: 10.1016/j.cmet.2021.02.013. Cell Metab. 2021. PMID: 33657386
Comment on
-
A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis.Cell Metab. 2020 Nov 3;32(5):878-888.e6. doi: 10.1016/j.cmet.2020.06.005. Epub 2020 Jun 30. Cell Metab. 2020. PMID: 32610095 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
